The poster claims not to be a U.S. citizen. While I do generally agree with what you are saying with regard to phenethylamines and tryptamines, the
Controlled Substances Act and amendments don't apply to most countries in the same way the Federal Analog Act does in the States. Presumably the OP is
immune (he seems to be South/Central American). Obviously anyone in the U.S. making analogs of schedule I and II narcotics is taking an expensive
legal risk even if not intended for human consumption, unless they are properly licensed/certified (as many researchers are; I work/have worked in
labs that used otherwise schedule I analogs for research, as well as schedule II and III narcotics).
Even in the U.K., Australia, Canada, etc. their laws tend to ban only explicitly listed substances, and it's unlikely all countries need you to be
considered a professional to get the equivalent of Form 225 DEA approval, if this even exists in their jurisdiction. This form does require more than
just reporting data to the DEA, and needs you to prove educational background, experimental methodology, etc. for approval before acceptance. It can
be arbitrarily denied or revoked, or limited to different schedulings. The paperwork is not fun, and I discovered drug scheduling permissions don't
necessarily transfer between sub-schedules, requiring frequent resubmission of paperwork, which is bureaucratic and annoying.
More applicable to most countries is the International Narcotics Control Board, whose restrictions are very similar to U.S. narcotic scheduling and
listed precursors. Not every country follows this, though, as seen here:
http://www.undispatch.com/uruguay-vs-the-international-narco...
Ultimately, given the site rules, even if someone were able to verify U.S. law does not apply to them, and if they either don't violate INCB
regulations or if they are not applicable to them, this moderator post sums up forum decorum:
https://www.sciencemadness.org/whisper/viewthread.php?tid=19... |